Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-528-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Skin sensitisation (OECD 406): not sensisiting
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 Mar - 22 Apr 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted 17 Jul 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The test was done before LLNA as first-choice method for in-vivo testing was set into force.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 300 - 450 g
- Housing: singly or in pairs in solid-floor polypropylene cages furnished with woodflakes
- Diet: Guinea Pig FD1 Diet (Special Diets Services Limited, Witham, UK), ad libitum
- Water: mains tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 - 23
- Humidity (%): 30 - 70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route:
- intradermal
- Vehicle:
- other: arachis oil BP
- Concentration / amount:
- 5%
- Day(s)/duration:
- on Day 0; single injection
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100%
- Day(s)/duration:
- on Day 7; 48 h
- Adequacy of induction:
- other: highest concentration used causing mild-to-moderate skin irritation
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: ethanol/diethylphtalate (1:1)
- Concentration / amount:
- 75%
- Day(s)/duration:
- on Day 21; 24 h
- Adequacy of challenge:
- other: non-irritant concentration
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100%
- Day(s)/duration:
- on Day 21; 24 h
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 5 (controls), 10 (test groups)
- Details on study design:
- RANGE FINDING TESTS:
For the intradermal induction 2 concentrations of the test substance (1 and 5%) in arachis oil BP were injected intradermally into the clipped skin of two animals. The highest concentration (5%) induced only mild to moderate skin irritation and was selected for the main study. For the epicutaneous induction 2 animals (intradermally injected with FCA 10 days earlier) were treated with 4 concentrations of the test substance (25, 50, 75 and 100%). Applications were made to the clipped flanks under occlusive dressings for 48 hours. Due to a technical error arachis oil BP was used as the vehicle for formulating the test substance instead of ethanol/diethylphthalate 1:1. The highest concentration (100%) produced only mild to moderate dermal irritation and was selected for the topical induction stage of the main study.
For the epicutaneous challenge 2 animals (identically treated to the control animals of the main study up to Day 14) were treated with 4 concentrations of the test substance (25, 50 and 75% in ethanol/diethylphthalate 1:1 and 100%). Applications were made to the clipped flanks under occlusive dressings for 24 hours. The highest non-irritant concentration and one lower concentration were selected for the topical challenge stage of the main study.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/water
Injection 2: 5% test substance in arachis oil BP
Injection 3: 5% v/v formulation of test material in 1:1 preparation of FCA/water
Epicutaneous: test substance undiluted
- Control group:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA/water
Injection 2: arachis oil BP
Injection 3: 50% formulation of test material in 1:1 preparation of FCA/water
Epicutaneous: identical to the test group except that the test material was omitted
- Site: shoulder region (intradermal + epicutaneous)
- Frequency of applications: every 7 days
- Duration: Days 0 - 7
- Concentrations: intradermal 5%, epicutaneous 100%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 21
- Exposure period: 24 h
- Test groups: test substance and vehicle
- Control group: test substance and vehicle
- Site: right flank (100% test substance) and left flank (75% test substance)
- Concentrations: 75 and 100%
- Evaluation: 24 and 48 h after challenge patch removal - Challenge controls:
- The control group is actually a challenge control.
- Positive control substance(s):
- yes
- Remarks:
- hexylcinnamaldehyde, Induction: intradermal 5% in arachis oil BP, epicutaneous 100%, Challenge: 75 and 100% in arachis oil BP
- Positive control results:
- The positive control substance induced positive reactions in 4/10 animals (40%), thus meeting the reliability criteria for the Guinea Pig Maximisation Test (≥ 30% positive response). The positive control group was not carried out concurrently with this study but is a historical background data group from a study performed during January and February 2001.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- Challenge: 75% in arachis oil BP
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Remarks on result:
- other: refer to "Positive control results"
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Challenge: 75%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: Challenge: 75%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Challenge: 100%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: Challenge: 100%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Challenge: 75%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: Challenge: 75%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Challenge: 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: Challenge: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Challenge: 75%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: Challenge: 75%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- Challenge: 100%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: Challenge: 100%. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Challenge: 75%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: Challenge: 75%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Challenge: 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: Challenge: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the guinea pig maximisation test the test substance revealed no sensitising properties.
Reference
Discrete or patchy to moderate and confluent erythema was noted at the intradermal induction sites of test group animals.
Discrete or patchy to moderate and confluent erythema was noted at the intradermal induction sites of control group animals.
Discrete or patchy to moderate and confluent erythema and an isolated incident of very slight oedema were noted at the topical induction sites of test group animals.
No skin reactions were noted at the topical induction sites of control group animals.
No skin reactions were noted at the challenge sites of the test or control group animals at the 24- or 48-hour observations.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The skin sensitising potential of the test substance was investigated in a guinea pig maximisation test (GPMT test) according to OECD Guideline 406 and in compliance with GLP (2001). A range finding study was performed to determine the appropriate dose level of the test substance in arachis oil BP following intradermal and epicutaneous administrations. Based on the results of the preliminary study, a 5% solution of the test substance in arachis oil BP was selected for the first induction stage (intradermal) on Day 0 and the undiluted test substance for the second induction stage (epicutaneous) on Day 7. A 75% solution of the test substance in ethanol/diethylphthalate 1:1 and the undiluted test substance were selected for the challenge on Day 21.
In the main study, 10 animals were used to investigate the skin sensitising potential of the test substance. In addition, 5 animals treated with arachis oil BP only served as vehicle reference. In the first induction stage on Day 0, discrete or patchy to moderate and confluent erythema was noted at the intradermal induction sites of the test or control group animals 24 and 48 h after administration. In the second induction stage on Day 7, a filter paper patch saturated with the undiluted test substance was applied to the clipped flanks under occlusive dressings for 48 h. Discrete or patchy to moderate and confluent erythema and an isolated incident of very slight oedema were noted at the topical induction sites of the test group animals. No skin reactions were noted at the topical induction sites of the control group animals. On Day 21, the animals were challenged with the 75% solution of the test substance in ethanol/diethylphthalate 1:1 and the undiluted test substance by occluded patches for 24 h to the left and right flank, respectively. No skin reactions at the challenge sites of the test or control group animals were observed 24 and 48 h after challenge patch removal. Based on the results of this GPMT, the test substance was not regarded as a skin sensitizer under the conditions of the test.
Migrated from Short description of key information:
skin sensitisation (OECD 406): not sensitising
Justification for selection of skin sensitisation endpoint:
The reliable GLP compliant OECD Guideline study was chosen.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
Justification for selection of respiratory sensitisation endpoint:
Study not required according to Annex VII-X of Regulation (EC) No 1907/2006.
Justification for classification or non-classification
The available data on sensitisation of the test substance do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.